Calcium Channel Blockers: The Effect of Glutathione S-Transferase Enzyme Activity and Molecular Docking Studies

TÜRKEŞ C., Kesebir A. Ö., Demir Y., KÜFREVİOĞLU Ö. İ., Beydemir Ş.

ChemistrySelect, vol.6, no.40, pp.11137-11143, 2021 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 6 Issue: 40
  • Publication Date: 2021
  • Doi Number: 10.1002/slct.202103100
  • Journal Name: ChemistrySelect
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier
  • Page Numbers: pp.11137-11143
  • Keywords: Biological Activity, Calcium Channel Blockers, Enzymes, Glutathione S-Transferase, Inhibition
  • Erzincan Binali Yildirim University Affiliated: Yes


© 2021 Wiley-VCH GmbH.Recently, as a drug target in cancer treatment, the superfamily of glutathione S-transferase (GSTs, EC have been invited considerable interest by scientists. In particular, as they are overexpressed in many human cancer cell lines, GSTs can catalyze the conjugation of the cellular nucleophile glutathione (GSH) with a wide range of electrophilic carcinogens toxins and drugs, meanwhile producing oxidative stress. For this purpose, the GST was purified by GSH-agarose affinity chromatography, and some calcium channel blockers (CCBs), such as amlodipine, cinnarizine, isradipine, nifedipine, and nilvadipine, were assessed for their inhibitory actions against GST. The CCBs demonstrated micromolar levels inhibitory activity towards GST (KIs spanning within the 98.84±0.53 μM–502.70±2.53 μM range). The best GST inhibitory activity was observed for the isradipine. Additionally, molecular docking study was performed for competitive inhibitor nilvadipine on GST to describe the possible interaction with the active site to confirm the inhibitory activity.